Todd S. Thomson

CIK: 0001225707

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)1 (14.3%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)6 (85.7%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

ACTU

ACTUATE THERAPEUTICS, INC.

Director

ZOOZ

ZOOZ Strategy Ltd.

Director

Discretionary Trading P&L

Holdings

Transaction History (7 total)

ACTU
ACTUATE THERAPEUTICS, INC.
Oct 28, 2026
Award(A)
Warrants (right to buy)
Indirect
269K shares-
ACTU
ACTUATE THERAPEUTICS, INC.
Oct 28, 2026
Award(A)
Warrants (right to buy)
Indirect
259.6K shares-
ACTU
ACTUATE THERAPEUTICS, INC.
Oct 28, 2026
Award(A)
Warrants (right to buy)
Indirect
75.7K shares-
ACTU
ACTUATE THERAPEUTICS, INC.
Oct 28, 2026
Award(A)
Warrants (right to buy)
Indirect
95.7K shares-
ACTU
ACTUATE THERAPEUTICS, INC.
May 21, 2026
Award(A)
Stock Options
Direct
15K shares-
ACTU
ACTUATE THERAPEUTICS, INC.
Jan 5, 2026
Sale(S)
Indirect
280K shares at avg. $5.80$1.6M
ACTU
ACTUATE THERAPEUTICS, INC.
May 22, 2025
Award(A)
Stock Options
Direct
15K shares-

		Type	Shares	Price		Ownership
Oct 28, 2026	ACTU ACTUATE THERAPEUTICS, INC.	Award(A) Warrants (right to buy)	269,017	-	-	Indirect
Oct 28, 2026	ACTU ACTUATE THERAPEUTICS, INC.	Award(A) Warrants (right to buy)	259,572	-	-	Indirect
Oct 28, 2026	ACTU ACTUATE THERAPEUTICS, INC.	Award(A) Warrants (right to buy)	75,738	-	-	Indirect
Oct 28, 2026	ACTU ACTUATE THERAPEUTICS, INC.	Award(A) Warrants (right to buy)	95,673	-	-	Indirect
May 21, 2026	ACTU ACTUATE THERAPEUTICS, INC.	Award(A) Stock Options	15,000	-	-	Direct
Jan 5, 2026	ACTU ACTUATE THERAPEUTICS, INC.	Sale(S)	280,000	$5.80	$1,624,000	Indirect
May 22, 2025	ACTU ACTUATE THERAPEUTICS, INC.	Award(A) Stock Options	15,000	-	-	Direct

1-7 of 7 transactions

About THOMSON TODD S

THOMSON TODD S (SEC CIK 0001225707) files insider reports with the SEC as Director of ACTUATE THERAPEUTICS, INC. (ACTU) and Director of ZOOZ Strategy Ltd. (ZOOZ).

Signal8 holds 5 ownership filings by THOMSON TODD S (1 Form 3, 4 Form 4), filed between May 23, 2025 and Nov 2, 2026. Those filings report 7 transactions, from May 22, 2025 to Oct 28, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on THOMSON TODD S's filings is in BEVERLY HILLS, CA.

Recent filings by THOMSON TODD S

Oct 28, 2026: Grants or awards of ACTU derivative securities (4 lines, Form 4, code A).
May 21, 2026: Grant or award of ACTU derivative securities (Form 4, code A).
Jan 5, 2026: Open-market sale of ACTU shares (Form 4, code S).
May 22, 2025: Grant or award of ACTU derivative securities (Form 4, code A).

Other insiders filing for ACTUATE THERAPEUTICS, INC. (ACTU)

BIOS Fund III, LP, Director
BIOS Fund I, LP, Director
SCHMITT DANIEL M, President, CEO and Director
Zabrowski Dan, Director
Sawhney Roger, Director
RONNEBERG AMY L, Director

How to read Form 4 transaction codes